Claritev price target raised to $86 from $44 at Piper Sandler

Piper Sandler raised the firm’s price target on Claritev (CTEV) to $86 from $44 and keeps an Overweight rating on the shares. The firm hopes Q2’s beat and raise marked the beginning of a new operating regime at Claritev. From here, Piper thinks multiple expansion is limited by the company’s risk profile – specifically antitrust risk and customer concentration risk.